Skip to main content
Equibles
VTR logo

VTR · Ventas, Inc. · Metrics

Track VTR — free

Use VTR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VTR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$89.85 +0.65 (+0.73%) Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$47.17B
Shares
528.82M
Volume · Nov 4 4.62M Avg daily vol (3M) 3.61M

VTR metrics

83 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$89.20
Market cap
$47.17B

Price action

20 metrics
Price change (1W)
+4.4%
Price change (30D)
+7.0%
Price change (3M)
-4.2%
Price change (6M)
+0.3%
Price change (YTD)
+12.5%
Price change (1Y)
+17.4%
Trailing year
Price change (5Y)
+58.7%
52-week high
$100.53
52-week low
$74.13
Change from 52-week high
-13.4%
Change from 52-week low
+17.4%
Annualized volatility
22.8%
Annualized volatility (3M)
24.7%
Beta
-0.3
RSI (14D)
54.8
Price vs SMA 50
+0.2%
Price vs SMA 200
+0.5%
Avg volume (3M)
3.59M
Relative volume
0.7
Average dollar volume
$313.01M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
528.82M

Valuation

14 metrics
P / FFO
25.0×
Company-stated · FY2025 · reciprocal yield 4.0%
P / AFFO
—
P / E (TTM)
164.2
Trailing earnings · reciprocal yield 0.6%
PEG ratio
—
EV / revenue
8.6×
reciprocal yield 11.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.7%
P / book
2.9
reciprocal yield 34.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
24.1
reciprocal yield 4.2%
Earnings yield
0.6%

Historical valuation

8 metrics
P / E historical average (3Y)
653.7×
reciprocal yield 0.2%
P / E historical average (5Y)
571.6×
reciprocal yield 0.2%
EV / revenue historical average (3Y)
8.1×
reciprocal yield 12.4%
EV / revenue historical average (5Y)
8.0×
reciprocal yield 12.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.3%
Trailing 12 months
Payout ratio
359.5%
Shareholder yield
2.1%
Dividend / share (TTM)
$2.04
Dividend growth YoY
+7.9%
Dividend growth streak
1
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
4.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$271.54M
Trailing 12 months
Diluted EPS (TTM)
$0.53
FCF margin
—
Effective tax rate
-28.4%

Per share

13 metrics
FFO per diluted share
$3.48
Company-stated · FY2025
AFFO per diluted share
—
Revenue per diluted share (TTM)
$13.66
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.55
Operating cash flow per diluted share (TTM)
$3.85
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.09
Book value per share
$26.38

Growth

11 metrics
Revenue growth YoY
+23.0%
Year over year
Net income growth YoY
-2.1%
Revenue (TTM)
$6.78B
Trailing 12 months
EPS growth YoY
-7.1%
Shares change YoY
+12.0%
Year over year · more shares
Revenue CAGR (3Y)
+12.2%
Revenue CAGR (5Y)
+9.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-14.3%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.7%
Return on assets
0.9%
Debt / equity
0.8
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$12.23B
Latest balance sheet
Cash & equivalents
$202.01M
Total assets
$30.63B
Total debt
$12.44B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.91B
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$42.40M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

9 metrics
13F filers
966
13F filer change QoQ
+23
Institutional ownership
98.8%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.4%
Holder tenure
17.7
Price vs estimated holder cost
+28.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
25.1%

Short interest

3 metrics
Short interest
2.7%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 740260 CUSIP 92276F100 13F (30d) 436 filings 403 filers Visit website Investor relations